Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.a

Pneumonitis (interstitial lung disease/ILD)

Publications

Pereira FM, Marques C, Boncoraglio T, Esteves J, Silva M, Braga J, Ribeiro M

Mesalazine-induced Hypersensitivity Pneumonitis.

European journal of case reports in internal medicine 2021;8;002194 — 2021 — 002194

Sossai P, Cappellato MG, Stefani S

Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.

The Mount Sinai journal of medicine, New York 2001 Nov;68;389-95 — 2001 Nov — 389-95

Reinoso MA, Schroeder KW, Pisani RJ

Lung disease associated with orally administered mesalamine for ulcerative colitis.

Chest 1992 May;101;1469-71 — 1992 May — 1469-71